Elunonavir
Elunonavir (GS-1156) is a HIV protease inhibitor with a high barrier to resistance and excellent metabolic stability. Elunonavir is able to overcome rapid CYP-mediated metabolism, resulting in a significantly prolonged half-life and the potential to reduce dosing frequency without the need for pharmacokinetic enhancers[1].
Product Specifications
CAS Number
2242428-57-3
UNSPSC
12352005
Target
HIV Protease
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/elunonavir.html
Smiles
O=C(N[C@@H](CC1=CC=C(C#CC2=CN=C(N=C2)N3CC4CCC(C3)N4C5COC5)C=C1)[C@H](CN(CC(C(F)=C6)=C(F)C=C6C7=NN(C(F)F)C=C7)NC([C@@H](NC(OC)=O)C(C)(C(F)(F)F)C)=O)O)[C@@H](NC(OC)=O)C(C)(C(F)(F)F)C
Molecular Formula
C52H59F10N11O8
Molecular Weight
1156.08
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RD-MIP1a-c-01 96 Tests
Canine Macrophage Inflammatory Protein 1 Alpha (MIP1a) ELISA Kit
Sign In for Pricing
View Details